Literature DB >> 1260391

Hazards of monocomponent insulins.

A W Logie, J M Stowers.   

Abstract

Mesh：

Substances：

Year:  1976        PMID： 1260391      PMCID： PMC1639570          DOI： 10.1136/bmj.1.6014.879-a

Source DB:  PubMed          Journal:  Br Med J        ISSN： 0007-1447


× No keyword cloud information.
  4 in total

1.  Antigenicity of "monocomponent" pork insulin in diabetic subjects.

Authors:  D K Yue; J R Turtle
Journal:  Diabetes       Date:  1975-07       Impact factor: 9.461

2.  Comparative trials with monocomponent (MC) and monospecies (MS) pork insulins in the treatment of diabetes mellitus. Influence on antibody levels, on insulin requirement and on some complications.

Authors:  D Andreani; M Iavicoli; G Tamburrano; G Menzinger; C Maltarello
Journal:  Horm Metab Res       Date:  1974-11       Impact factor: 2.936

3.  Serum levels of insulin-binding antibodies in diabetic patients treated with monocomponent insulin.

Authors:  A Czyzyk; J Lawecki; H Rogala; E Miedzińska; A Popik-Hankiewicz
Journal:  Diabetologia       Date:  1974-06       Impact factor: 10.122

4.  Clinical aspects of insulin--antigenicity.

Authors:  J Schlichtkrull; J Brange; A H Christiansen; O Hallund; L G Heding; K H Jorgensen
Journal:  Diabetes       Date:  1972       Impact factor: 9.461
  4 in total
  8 in total

1.  Insulin-binding antibody: reaction differences with bovine and porcine insulins.

Authors:  A B Kurtz; J A Matthews; J D Nabarro
Journal:  Diabetologia       Date:  1978-07       Impact factor: 10.122

2.  Reduction of insulin dose on changing diabetic children from standard to monocomponent insulins.

Authors:  N K Griffin; M A Smith; J D Baum
Journal:  Arch Dis Child       Date:  1979-02       Impact factor: 3.791

3.  Very pure porcine insulin in clinical practice.

Authors:  A D Wright; C H Walsh; M G Fitzgerald; J M Malins
Journal:  Br Med J       Date:  1979-01-06

4.  Highly purified insulins.

Authors:  K G Alberti; M Nattrass
Journal:  Diabetologia       Date:  1978-08       Impact factor: 10.122

5.  Antibody formation and insulin requirements in diabetic children during treatment with purified commercial pork insulins.

Authors:  B Weber; J Tech; H Schmidt; U Oberdisse
Journal:  Eur J Pediatr       Date:  1978-06-20       Impact factor: 3.183

6.  Insulin binding capacity in patients changed from conventional to highly purified insulins. An indicator of likely response.

Authors:  B E Mustaffa; P R Daggett; J D Nabarro
Journal:  Diabetologia       Date:  1977-08       Impact factor: 10.122

Review 7.  The new insulins. Their characteristics and clinical indications.

Authors:  P D Home; K G Alberti
Journal:  Drugs       Date:  1982-11       Impact factor: 9.546

8.  Change of insulin dosage, circulating free and bound insulin and insulin antibodies on transferring diabetics from conventional to highly purified porcine insulin.

Authors:  C M Asplin; M Hartog; D J Goldie
Journal:  Diabetologia       Date:  1978-02       Impact factor: 10.122
  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.